title: Why is the management of asymptomatic carotid disease so controversial?
abstract: BACKGROUND
  Despite level I evidence supporting a role for carotid endarterectomy (CEA) in the management of patients with asymptomatic carotid disease, there is surprisingly little international consensus regarding the optimal way to manage these patients.
  
  
  METHODS
  Review of current strategies for managing asymptomatic carotid disease
  
  
  RESULTS
  Those favouring a pro-interventional approach argue that: (i) until new randomised trials demonstrate that best medical therapy (BMT) is better than CEA or carotid artery stenting (CAS) in preventing stroke, guidelines of practice should remain unchanged; (ii) strokes secondary to carotid thromboembolism harboured a potentially treatable asymptomatic lesion prior to the event. Because 80% of strokes are not preceded by a TIA/minor stroke, CEA/CAS is the only way of preventing these strokes; (iii) screening for carotid disease could identify patients with significant asymptomatic stenoses who could undergo prophylactic CEA/CAS in order to prevent avoidable stroke; (iv) international guidelines already advise that only 'highly-selected' patients should undergo CEA/CAS; (v) the 30-day risks of death/stroke after CEA/CAS are diminishing and this will increase long-term stroke prevention and (vi) the alleged decline in annualized stroke rates in medically treated patients is based upon flawed data.
  
  
  CONCLUSIONS
  The inescapable conclusion is that only a relatively small proportion of asymptomatic patients benefit from prophylactic CEA/CAS. The key question, therefore, remains; is society prepared to invest sufficient resources in identifying these 'high risk for stroke' patients so that they can benefit from aggressive BMT and CEA or CAS, leaving the majority of lower risk patients to be treated medically?
authors.affiliation: The Department of Vascular Surgery at Leicester Royal Infirmary, Leicester, United Kingdom. Electronic address: ross.naylor@uhl-tr.nhs.uk.
authors.forename: A Ross
authors.initials: AR
authors.lastname: Naylor
mesh_terms: D058070:Asymptomatic Diseases; D016893:Carotid Stenosis / Q000150:complications / Q000601:surgery*; D016894:Endarterectomy, Carotid; D006801:Humans; D015607:Stents; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*
keywords: Asymptomatic carotid disease; Carotid artery stenting; Carotid endarterectomy; Stroke